Naritoshi Mukumoto
Papers
2
Total Citations
13
H-Index
2
About
Naritoshi Mukumoto is a leading researcher in radiation oncology, specializing in stereotactic body radiation therapy (SBRT) and advanced motion management techniques. His work is pivotal in refining the CyberKnife robotic radiosurgery system, particularly for treating liver and lung tumors. Mukumoto’s major contributions include pioneering investigations into fiducial marker tracking regimens for liver tumors, where his 2019 study (11 citations) critically assessed the uncertainties of single-marker tracking in the CyberKnife Synchrony system—a key step toward simplifying and improving the accuracy of real-time tumor motion tracking. He has also advanced treatment planning for lung SBRT, notably comparing supine versus prone positioning for different tumor locations (2021, 2 citations), addressing the unique geometric constraints of the CyberKnife’s ceiling-to-floor beam delivery. This work has direct implications for optimizing dose delivery to posterior lung tumors, enhancing treatment efficacy and reducing toxicity. Mukumoto’s research, though early in citation impact, is foundational for clinical protocols in robotic SBRT, demonstrating a focused commitment to solving practical challenges in precision radiotherapy. His studies are essential reading for students and clinicians seeking to understand motion management and treatment planning in modern stereotactic radiation therapy.
Research Focus
Key Achievements
Top Papers
- 1
- 2